Verition Fund Management’s Sight Sciences SGHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,600
Closed -$92K 3392
2025
Q4
$92K Hold
11,600
﹤0.01% 3332
2025
Q3
$39.9K Sell
11,600
-8,409
-42% -$31.3K ﹤0.01% 3664
2025
Q2
$82.6K Buy
+20,009
New +$66.8K ﹤0.01% 3497
2024
Q3
Sell
-13,875
Closed -$92.5K 3482
2024
Q2
$92.5K Buy
+13,875
New +$82K ﹤0.01% 2735
2023
Q4
Sell
-15,100
Closed -$50.9K 2646
2023
Q3
$50.9K Buy
+15,100
New +$99.2K ﹤0.01% 2185

Other funds holding SGHT

Verition Fund Management's SGHT Position: Q1 2026 in Review

Verition Fund Management sold out of Sight Sciences (SGHT) in Q1 2026, closing a stake of 11,600 shares — an estimated $92K sold.

Verition Fund Management first reported a position in SGHT in Q3 2023 and held it in 5 quarters. The position peaked at $92.5K in Q2 2024. 114 funds tracked by Wall St. Rank hold SGHT as of Q1 2026.

  • Verition Fund Management reported no remaining Sight Sciences position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 11,600 Sight Sciences shares in Q1 2026, an estimated $92K.
  • Verition Fund Management first reported a position in Sight Sciences in Q3 2023 and held it in 5 quarters.
  • Verition Fund Management's Sight Sciences position peaked at $92.5K in Q2 2024.
  • 114 funds tracked by Wall St. Rank held Sight Sciences as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.